A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients

This was a phase I/II study testing the feasibility of a vaccine by autologous leukemic apoptotic corpse-pulsed dendritic cells (DC) in elderly acute myeloid leukemia (AML) patients in first or second complete remission. Pulsed DC were administered at doses of 9 × 106 subcutaneously (1 mL) and 1 × 1...

Cijeli opis

Bibliografski detalji

Glavni autori:	Patrice Chevallier, Soraya Saiagh, Virginie Dehame, Thierry Guillaume, Pierre Peterlin, Sylvain Bercegeay, Yannick Le Bris, Céline Bossard, Isabelle Gauvrit, Brigitte Dreno, Nadine Juge-Morineau, Marie C. Béné, Marc Gregoire
Format:	Artigo
Jezik:	Inglês
Izdano:	Taylor & Francis Group 2021-10-01
Serija:	Human Vaccines & Immunotherapeutics
Teme:	dendritic cells vaccine aml apoptotic corpses
Online pristup:	http://dx.doi.org/10.1080/21645515.2021.1943991
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!